IWR-1-endo

Potent and reversible cell permeable Wnt pathway signaling inhibitor. Inhibits Wnt-induced accumulation of beta-catenin, leading to proteasomal degradation of this protein through a destruction complex which consists of Apc, Axin2, CK1 and GSK-3beta. Stabilizes the destruction complex, increasing the level of Axin2 protein without changing the levels of Apc or GSK-3beta. Tankyrase-1 (TNKS1/PARP5a) and Tankyrase-2 (TNKS2/PARP5b) inhibitor (in vitro auto-PARsylation assay).

Price Not Available 5 mg IWR-1-endo Supplier Page
Catalog Number AG-CR1-3581-M005
Alternative Name(s) 4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide
Research Area Biochemicals, Cancer, Inflammation, Metabolism, Neurodegenerative Disease, Stem Cell Research
Molecular Formula C25H19N3O3
CAS# 1127442-82-3
Purity >98%
Inchi InChI=1/C25H19N3O3/c29-23(27-19-5-1-3-14-4-2-12-26-22(14)19)15-8-10-18(11-9-15)28-24(30)20-16-6-7-17(13-16)21(20)25(28)31/h1-12,16-17,20-21H,13H2,(H,27,29)/t16?,17?,20-,21+/f/h27H
Inchi Key ZGSXEXBYLJIOGF-UBYGHTOYDO
SMILES [H][C@@]12C3CC(C=C3)[C@]1([H])C(=O)N(C2=O)C1=CC=C(C=C1)C(=O)NC1=C2N=CC=CC2=CC=C1
Size 5 mg
Supplier Page http://www.adipogen.com/ag-cr1-3581/iwr-1-endo.html